Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of AZD0530 on subjects with breast
cancer or prostate cancer with metastatic bone disease in comparison to zoledronic acid.